Antitetanus Vaccination for People Older Than 65 Years.
NCT03266211 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 261
Last updated 2018-06-12
Summary
In the last ten years, more than one hundred generalized tetanus cases were declared in France. Most of them were affecting people older than 70 years with an important mortality (around 28%). It is know that the only way to protect ourselves from this disease is the vaccination. In France tetanus vaccination is mandatory since 1940.
Nowaday none study looked specifically for the vaccination of people older than 65 years. The hypothesis is: there is a difference in the tetanus vaccination coverage for people older than 65 years depending on the demographic and medical practice of their general practitioner.
Conditions
- Tetanus
Interventions
- OTHER
-
Questionnaire Patients
Patient will have to answer a quiz which is about their vaccination against tetanus.
- OTHER
-
Questionnaire General practitioner
General practitioner will have to answer a quiz which is about their medical practice concerning vaccination against tetanus.
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-11-09
- Primary Completion
- 2017-12-23
- Completion
- 2017-12-23
Countries
- France
Study Locations
More Related Trials
-
Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
NCT01323959 ·Status: COMPLETED ·Phase: PHASE4
-
Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective Levels
NCT00437671 ·Status: TERMINATED ·Phase: PHASE4
-
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose
NCT01439165 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over
NCT06120751 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Adacel® Vaccine Administered to Persons 10 Years of Age
NCT01311557 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)
NCT06056050 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents
NCT02118961 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children ( DTaP/DT )
NCT05870631 ·Status: UNKNOWN ·Phase: PHASE4
-
Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian
NCT04741828 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Dose Ranging Study of Acellular Pertussis and Acellular Pertussis -Tetanus-Diphtheria Booster Vaccines in Healthy Adults Ages 18 to 40 Years
NCT01529645 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents
NCT01689324 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine
NCT02813486 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Tdap Vaccine Safety for Plasma Donors
NCT04142983 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With Td
NCT01338688 ·Status: COMPLETED
-
Immunogenicity and Safety of DTaP or DT Vaccine in 6 Year Old Children
NCT05870618 ·Status: UNKNOWN ·Phase: PHASE4
-
A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
NCT05091619 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old Population
NCT06049940 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents
NCT01629589 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058
NCT00548171 ·Status: COMPLETED ·Phase: PHASE4
-
Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .
NCT04099303 ·Status: COMPLETED ·Phase: PHASE1
-
Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9
NCT00489970 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose
NCT00712959 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine
NCT00514059 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis Vaccine
NCT01262924 ·Status: COMPLETED ·Phase: PHASE3